Market research
IX1.F IDEXX Laboratories, Inc
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 34B
- P/E ratio
- 35.72
- Analyst target
- 707
- Dividend yield
- Not available
- Beta
- 1.54
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- ISIN
- US45168D1046
- Market cap
- 34B
- P/E ratio
- 35.72
- Analyst target
- 707
- Dividend yield
- Not available
- Beta
- 1.54
About
About IDEXX Laboratories, Inc
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the IX1.F discussion.
5 years, 5 months ago
IDEXX Laboratories, Inc is currently in a long term uptrend where the price is trading 31.1% above its 200 day moving average.
From a valuation standpoint, the stock is 98.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 15.6.
IDEXX Laboratories, Inc's total revenue rose by 19.1% to $721M since the same quarter in the previous year.
Its net income has increased by 93.1% to $175M since the same quarter in the previous year.
Finally, its free cash flow grew by 87.0% to $205M since the same quarter in the previous year.
Based on the above factors, IDEXX Laboratories, Inc gets an overall score of 5/5.